PharmaPoint Meningococcal Vaccines
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
9.2 Trends in Corporate Strategy 165<br />
9.3 Company Profiles 167<br />
9.3.1 Sanofi 167<br />
9.3.2 Pfizer 170<br />
9.3.3 GlaxoSmithKline 172<br />
9.4 Former Players 175<br />
9.4.1 Novartis 175<br />
9.4.2 Baxter 177<br />
9.4.3 Nuron Biotech 177<br />
10 Market Outlook 179<br />
10.1 Global Markets 179<br />
10.1.1 Forecast 179<br />
10.1.2 Drivers and Barriers - Global Issues 183<br />
10.2 United States 186<br />
10.2.1 Forecast 186<br />
10.2.2 Key Events 191<br />
10.2.3 Drivers and Barriers 192<br />
10.3 France 195<br />
10.3.1 Forecast 195<br />
10.3.2 Key Events 199<br />
10.3.3 Drivers and Barriers 200<br />
10.4 Germany 201<br />
10.4.1 Forecast 201<br />
10.4.2 Key Events 205<br />
10.4.3 Drivers and Barriers 206<br />
10.5 Italy 207<br />
10.5.1 Forecast 207<br />
10.5.2 Key Events 211<br />
10.5.3 Drivers and Barriers 212<br />
10.6 Spain 213<br />
10.6.1 Forecast 213<br />
10.6.2 Key Events 217<br />
10.6.3 Drivers and Barriers 218<br />
10.7 United Kingdom 219<br />
10.7.1 Forecast 219<br />
10.7.2 Key Events 223<br />
10.7.3 Drivers and Barriers 224<br />
10.8 Japan 225<br />
10.8.1 Drivers and Barriers 225<br />
10.9 Australia 226<br />
10.9.1 Forecast 226<br />
10.9.2 Key Events 230<br />
10.9.3 Drivers and Barriers 231<br />
10.10 Brazil 232<br />
10.10.1 Forecast 232<br />
10.10.2 Key Events 236<br />
10.10.3 Drivers and Barriers 237<br />
5
Change language